NEPH Stock: Nephros, Inc. Stock Price, Analysis & Insights
Get live NEPH stock price $3.29, comprehensive Nephros, Inc. stock analysis, charts, news, and expert forecast. Real-time NEPH stock data and investment insights.
Loading chart data...
Nephros, Inc. (NEPH) Overview
Nephros, Inc. (NEPH) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, NEPH trades at $3.29 with a market capitalization of 35.72M . Over the past 52 weeks, NEPH has traded between $2.66 and $6.42 , with the current price positioned at approximately 17% of this range . The stock currently...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 35.72M
- Current price: $3.29
- 52-week range: $2.66 - $6.42
- P/E ratio: 47.00
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segment...
Company Information
- CEO
- Robert Banks
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 31
Contact Information
- Website
- https://www.nephros.com
- Address
- 380 Lackawanna Place
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 47.0)
✓ Higher growth potential with elevated volatility (Beta: 1.50)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Nephros, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Nephros, Inc.
- ⚠Investors should consider how Nephros, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 47.0) requires strong growth to justify
Market Cap
35.72M
P/E Ratio (TTM)
47.00
Beta
1.50
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NEPH with peer companies:
- Price
- $0.75-1.18% (1D)
- Market cap
- 25.99M
- Price
- $10.00+2.46% (1D)
- Market cap
- 50.39M
- Price
- $0.38+3.97% (1D)
- Market cap
- 18.44M
- Price
- $9.75-0.41% (1D)
- Market cap
- 88.21M
- Price
- $3.83+2.13% (1D)
- Market cap
- 66.20M
- Price
- $0.59-2.65% (1D)
- Market cap
- 31.91M
- Price
- $1.73+1.77% (1D)
- Market cap
- 76.83M
- Price
- $1.11+24.34% (1D)
- Market cap
- 45.46M
- Price
- $49.16+3.49% (1D)
- Market cap
- 67.44M
- Price
- $2.37+0.21% (1D)
- Market cap
- 18.51M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
88/100 ⭐⭐⭐⭐⭐
- Overall
- +1.1%
- NYSE
- +1.2%
- NASDAQ
- +0.9%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Healthcare | +1.1% | -1.3% | +2.0% | 30.6 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.3% | +1.2% | +1.2% | 19.2 | 79/100⭐⭐⭐⭐⭐ |
| Industrials | +0.8% | -4.3% | +1.4% | 42.1 | 72/100⭐⭐⭐⭐⭐ |
| Energy | -0.6% | -6.5% | +1.2% | 37.0 | 68/100⭐⭐⭐⭐ |
| Communication Services | -1.5% | -3.1% | -0.2% | 21.5 | 62/100⭐⭐⭐⭐ |
| Technology | +0.1% | -6.8% | +0.9% | 49.5 | 48/100⭐⭐⭐ |
| Basic Materials | +0.1% | -4.0% | -1.5% | 26.9 | 42/100⭐⭐⭐ |
| Real Estate | -0.2% | -1.1% | -1.2% | 49.6 | 31/100⭐⭐ |
| Utilities | +0.9% | -4.0% | -5.7% | 25.6 | 24/100⭐ |
| Consumer Defensive | -0.2% | +2.1% | -2.4% | 31.2 | 22/100⭐ |
| Consumer Cyclical | -0.4% | -3.4% | -2.3% | 52.7 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.